云顶新耀:美国FDA批准肿瘤相关抗原疫苗EVM14的新药临床试验申请

每日经济新闻
24 Mar

每经AI快讯,3月24日,云顶新耀官微宣布,通用型的现货肿瘤治疗性疫苗EVM14成功获得美国FDA IND批准,成为云顶新耀首款自研进入全球临床阶段的mRNA肿瘤治疗性疫苗。(文章来源:每日经济新闻)

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10